Metropolitan Life Insurance Company (MetLife)’s Senseonics Holdings Inc SENS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,289
Closed -$18.3K 2508
2023
Q1
$18.3K Sell
1,289
-94
-7% -$1.89K ﹤0.01% 1924
2022
Q4
$28.5K Hold
1,383
﹤0.01% 1813
2022
Q3
$36.5K Buy
1,383
+527
+62% +$16.1K ﹤0.01% 1676
2022
Q2
$17.6K Sell
856
-536
-39% -$14K ﹤0.01% 2102
2022
Q1
$54.9K Sell
1,392
-3,486
-71% -$160K ﹤0.01% 1544
2021
Q4
$261K Sell
4,878
-148
-3% -$9.62K ﹤0.01% 1832
2021
Q3
$341K Sell
5,026
-813
-14% -$55.2K ﹤0.01% 1686
2021
Q2
$448K Buy
+5,839
New +$296K 0.01% 1588
2019
Q3
Sell
-1,319
Closed -$53.8K 2617
2019
Q2
$53.8K Hold
1,319
﹤0.01% 2498
2019
Q1
$64.6K Buy
1,319
+105
+9% +$5.58K ﹤0.01% 2490
2018
Q4
$62.9K Hold
1,214
﹤0.01% 2493
2018
Q3
$116K Hold
1,214
﹤0.01% 2366
2018
Q2
$99.8K Buy
+1,214
New +$87K ﹤0.01% 2321

Other funds holding SENS

Metropolitan Life Insurance Company (MetLife)'s SENS Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Senseonics Holdings Inc (SENS) in Q2 2023, closing a stake of 1,289 shares — an estimated $18.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SENS in Q2 2018 and held it in 13 quarters. The position peaked at $448K in Q2 2021. 159 funds tracked by Wall St. Rank hold SENS as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Senseonics Holdings Inc position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,289 Senseonics Holdings Inc shares in Q2 2023, an estimated $18.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Senseonics Holdings Inc in Q2 2018 and held it in 13 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Senseonics Holdings Inc position peaked at $448K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Senseonics Holdings Inc as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.